- Viking Therapeutics Shorts Reap $514 Million as Stock Falls 40% Bloomberg
- Viking Therapeutics stock crashes after weight-loss pill trial shows high dropout rate Yahoo Finance
- Viking Therapeutics shares fall 40% on disappointing obesity pill trial data CNBC
- High drop-out rate clouds weight loss data for Viking’s oral drug FirstWord Pharma
- This Weight-Loss Stock Is Down 40%. It Lowers the Risks for Eli Lilly and Novo Nordisk. Barron’s
Source link
